INSR and myotonic dystrophy type 1: In vitro and in vivo experiments confirmed its ability to reduce ribonuclear foci and partially rescue misregulated splicing of cardiac troponin T (cTNT) and insulin receptor (IR), two preRNAs mis-spliced in the DM1 context.